文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

COVID-19休克患者可逆性心肌抑制与扩张

Reversible Myocardial Depression and Dilatation in COVID-19 Shock Patients.
PubMed 文献 · Crit Care Explor · 2025-06-13
一句话结论COVID-19休克患者左室射血分数降低与心室扩张在随访中可逆,每搏输出量无变化,表现与细菌/真菌性脓毒性休克相似。

该研究为队列研究,2020年3月至2021年12月期间368例住院COVID患者中,15例急性休克期超声心动图显示左室射血分数(LVEF)降低并进行了随访超声。LVEF以45%、心脏指数以2.2 L/min/m2为阈值分组。15例患者随访超声于初始值后中位13天(95%CI 9-39天)进行。与急性休克期相比,随访LVEF 43.8±3.47 vs 35.3±8.1(p=0.031),左室舒张末期容积152.1±12.9 mL vs 182±14.1 mL(p=0.025),收缩末期容积90.1±12.1 mL vs 120.2±13.1 mL(p=0.025),每搏输出量无显著变化(31.7±2.3 mL vs 29.6±1.9 mL,p=0.522)。作者认为COVID-19(病毒性)脓毒性休克的心肌功能障碍机制可能与细菌或真菌性脓毒症相似。

要点

  • COVID-19休克患者急性期LVEF降低(平均35.3±8.1%)与左室扩张,随访中位13天后LVEF升至43.8±3.47%(p=0.031)。
  • 随访左室舒张末期容积从182±14.1 mL降至152.1±12.9 mL(p=0.025),收缩末期容积从120.2±13.1 mL降至90.1±12.1 mL(p=0.025)。
  • 每搏输出量在急性期与随访间无显著变化(29.6±1.9 mL vs 31.7±2.3 mL,p=0.522)。
  • 作者认为COVID-19(病毒性)脓毒性休克的心肌抑制与扩张可逆,机制可能与细菌或真菌性脓毒症相似。

适用人群与场景

  • 2020年3月至2021年12月期间住院的COVID-19合并休克患者,来自368例住院COVID患者队列。
  • 其中15例在急性休克期超声心动图确定LVEF降低并进行了随访超声心动图。

诊断标准与关键阈值

  • LVEF由Simpson法测定,以45%为阈值将患者分为低值或正常值组。
  • 心脏指数(CI)以2.2 L/min/m2为阈值将患者分为低值或正常值组。
  • 每搏输出量(SV)由多普勒分析。

研究设计与关键结果

  • 研究类型为队列研究,样本量15例(来自368例住院COVID患者队列),人群为COVID-19休克患者。
  • 随访超声心动图于初始值后中位13天(95%CI 9-39天)进行。
  • 主要终点:与急性休克期相比,随访LVEF 43.8±3.47 vs 35.3±8.1(p=0.031),差异有统计学意义。
  • 左室舒张末期容积随访152.1±12.9 mL vs 急性期182±14.1 mL(p=0.025),收缩末期容积随访90.1±12.1 mL vs 急性期120.2±13.1 mL(p=0.025)。
  • 每搏输出量随访31.7±2.3 mL vs 急性期29.6±1.9 mL(p=0.522),差异无统计学意义。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为COVID-19(病毒性)脓毒性休克的心肌抑制与扩张可逆,机制可能与细菌或真菌性脓毒症相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: A characteristic pattern of bacterial and fungal septic shock is decreased left ventricular (LV) ejection fraction (LVEF) and modest dilatation of the LV. In survivors, the myocardial depression and dilatation are reversible within several days. In a cohort of 368 hospitalized COVID patients with shock from March 2020 to December 2021, 15 patients were identified with an echocardiogram determined depressed LVEF during acute shock, and a follow-up echocardiogram was performed.

OBJECTIVES: Myocardial dysfunction and dilatation associated with COVID-19 are reversible.

DESIGN, SETTING, AND PARTICIPANTS: LVEF was determined by Simpson's rule and stroke volume (SV) was analyzed by Doppler. Based on the LVEF and cardiac index (CI), patients were categorized into groups with low or normal values using an ejection fraction of 45% and CI 2.2 L/min/m2 as the respective thresholds. A subset of 15 patients underwent serial echocardiography, which was performed at a median of 13 days (95% CI, 9-39 d) after the initial value.

MAIN OUTCOMES AND MEASURES: The LVEF and LV volumes recorded during initial and follow-up echo were analyzed using paired t test.

RESULTS: Comparing initial during acute shock with follow-up values, the mean (± sd) LVEF was 35.3 ± 8.1 vs. 43.8 ± 3.47 (p = 0.031), indexed SV 29.6 ± 1.9 mL vs. 31.7 ± 2.3 mL (p = 0.522), LV end-diastolic volume 182 ± 14.1 mL vs. 152.1 ± 12.9 mL (p = 0.025), and LV end-systolic volume 120.2 ± 13.1 mL vs. 90.1 ± 12.1 mL (p = 0.025), respectively.

CONCLUSIONS AND RELEVANCE: Serial echocardiographic studies of COVID-19 shock patients with reduced LVEF and ventricular dilatation demonstrate reversibility of myocardial depression and dilation with no change in SV, a finding strikingly similar to that seen in bacterial and fungal-induced septic shock. Thus, COVID-19 (viral) induced septic shock may have a similar pathogenetic mechanism of myocardial dysfunction to that seen with bacterial or fungal sepsis.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Fata MJ, Hollenberg SM, Klinkhammer B, et al. Reversible Myocardial Depression and Dilatation in COVID-19 Shock Patients. Crit Care Explor. 2025. PMID: 40511904. doi:10.1097/CCE.0000000000001264

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。